Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, and cGMP facilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK.
Looking for a particular Abzena employee's phone or email?
The Abzena annual revenue was $112.7 million in 2026.
Geoffrey Glass is the CEO of Abzena.
389 people are employed at Abzena.
Abzena is based in San Diego, California.
The NAICS codes for Abzena are [339, 54171, 33, 54, 541, 541711, 5417].
The SIC codes for Abzena are [283, 28].